Carazo-Melo, F., Bertolo, C., Castilla, C., Cendoya-Garmendia, X., Campuzano, L., Serrano, D., . . . Rubio, A. (2023). DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC).
Chicago Style (17th ed.) CitationCarazo-Melo, F.(Fernando), et al. DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC). 2023.
MLA (8th ed.) CitationCarazo-Melo, F.(Fernando), et al. DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC). 2023.
Warning: These citations may not always be 100% accurate.